| Code | CSB-RA618973MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to reference antibody ZMA-001, targeting KARS1 (Lysyl-tRNA Synthetase 1). KARS1 is an aminoacyl-tRNA synthetase that catalyzes the attachment of lysine to its cognate tRNA molecule, a critical step in protein translation. Beyond its canonical role in translation, KARS1 participates in immune regulation through its secreted form, which acts as a signaling molecule in inflammatory responses. Mutations in KARS1 have been associated with Charcot-Marie-Tooth disease and other neurological disorders, while aberrant expression patterns have been observed in various cancers and autoimmune conditions.
This biosimilar antibody provides researchers with a reliable tool for investigating KARS1 function in cellular metabolism, protein synthesis regulation, and disease pathogenesis. It enables studies exploring the dual role of KARS1 in both housekeeping translation and extracellular signaling pathways. The antibody supports research into neurodegenerative diseases, cancer biology, and immune system dysregulation where KARS1 plays a significant role.
There are currently no reviews for this product.